References: (2013, April 30). Retrieved October 6, 2013, from Drugs.com: FDA Approves Procysbi. Bouazza, N., Tre'luyer, J., Ottolenghi, C., Urien, S., Deshenes, G., Ricquier, D., & B. (2011). Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients. Orphanet Journal of Rare Diseases, 1-8. Retrieved from http://www.ojrd.com/content/6/1/86 6(86), Cystinosis Research Network [CRN]. (2011). Survey, Living With Cystinosis: Survey Results. CRN. Retrieved October 14, 2013 Cystinosis Research Network [CRN]. (2012, October). Retrieved Cystinosis Parent Handbook. September 20, 2013, from Cystinosis Research Network: https://cystinosis.org/images/research/article-library/overview/CRN_Parent.pdf Elenberg, E. (2013, May 13). (C. B. Langman, Ed.) Retrieved October 6, 2013, from Cystinosis. Medscape: http://emedicine.medscape.com/article/981650-overview Fathallah-Shaykh, S. (2013, April 16). (C. B. Langman, Editor) Retrieved Fanconi Syndrome. October 8, 2013, from Medscape:
References: FDA Approves Procysbi. (2013, April 30). Retrieved October 6, 2013, from Drugs.com: Bouazza, N., Tre'luyer, J., Ottolenghi, C., Urien, S., Deshenes, G., Ricquier, D., & B. (2011). Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients. Orphanet Journal of Rare Diseases, 6(86), 1-8. Retrieved from http://www.ojrd.com/content/6/1/86 Cystinosis Research Network [CRN]. (2011). Living With Cystinosis: Survey Results. Survey, CRN. Retrieved October 14, 2013 Cystinosis Research Network [CRN]. (2012, October). Cystinosis Parent Handbook. Retrieved September 20, 2013, from Cystinosis Research Network: https://cystinosis.org/images/research/article-library/overview/CRN_Parent.pdf Elenberg, E. (2013, May 13). Cystinosis. (C. B. Langman, Ed.) Retrieved October 6, 2013, from Medscape: http://emedicine.medscape.com/article/981650-overview Fathallah-Shaykh, S. (2013, April 16). Fanconi Syndrome. (C. B. Langman, Editor) Retrieved October 8, 2013, from Medscape: